Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,101,179
-$113,151 QoQ
Shares Held
8,716
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1,030
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MITCHELL MCLEOD PUGH & WILLIAMS INC holds $30,637,991 across 10 Drug Manufacturers - General names. GILD ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,466 | $8,954,945 | |
| 2 | JNJ |
Johnson & Johnson
|
28,718 | $7,293,509 | |
| 3 | ABBV |
AbbVie Inc.
|
20,243 | $5,093,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,603 | $3,289,985 | |
| 5 | PFE |
Pfizer Inc
|
69,337 | $1,669,634 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,456 | $1,121,054 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
8,716 | $1,101,179 | |
| 8 | AMGN |
Amgen Inc
|
2,634 | $953,824 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,101,179 | 8,716 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,214,330 | 8,713 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,116,074 | 9,093 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,012,653 | 9,123 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,013,130 | 9,138 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,068,172 | 9,533 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $880,563 | 9,533 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $799,246 | 9,533 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $654,059 | 9,533 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $698,292 | 9,533 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $786,040 | 9,703 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $728,341 | 9,719 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $747,733 | 9,702 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $804,974 | 9,702 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $842,446 | 9,813 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $609,929 | 9,887 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $690,541 | 11,172 | Shares | Sole | 2022-11-18 | |
| 2022-03-31 | $681,178 | 11,458 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $868,923 | 11,967 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $857,897 | 12,282 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $845,738 | 12,282 | Shares | Sole | 2021-11-08 | |
| 2021-03-31 | $793,785 | 12,282 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $705,528 | 12,110 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $765,230 | 12,110 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $895,889 | 11,644 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $795,222 | 10,637 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||